[1]
Soung, J., King, B., Tziotzios, C., Rudnicka, L., Joly, P., Gooderham, M., Sinclair, R., Wajsbrot, D., Tran, H. and Wolk, R. 2023. Integrated Safety Analysis of Ritlecitinib in Adolescent Patients with Alopecia Areata from the Randomized, Placebo-Controlled ALLEGRO Phase 2b/3 and Ongoing Open-Label Phase 3 ALLEGRO-LT Studies. SKIN The Journal of Cutaneous Medicine. 7, 6 (Nov. 2023), s294. DOI:https://doi.org/10.25251/skin.7.supp.294.